Literature DB >> 21527912

Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.

Sathish Kumar1, Nasrollah Rezaei-Ghaleh, Dick Terwel, Dietmar R Thal, Mélisande Richard, Michael Hoch, Jessica M Mc Donald, Ullrich Wüllner, Konstantin Glebov, Michael T Heneka, Dominic M Walsh, Markus Zweckstetter, Jochen Walter.   

Abstract

Alzheimer's disease (AD) is the most common form of dementia and associated with progressive deposition of amyloid β-peptides (Aβ) in the brain. Aβ derives by sequential proteolytic processing of the amyloid precursor protein by β- and γ-secretases. Rare mutations that lead to amino-acid substitutions within or close to the Aβ domain promote the formation of neurotoxic Aβ assemblies and can cause early-onset AD. However, mechanisms that increase the aggregation of wild-type Aβ and cause the much more common sporadic forms of AD are largely unknown. Here, we show that extracellular Aβ undergoes phosphorylation by protein kinases at the cell surface and in cerebrospinal fluid of the human brain. Phosphorylation of serine residue 8 promotes formation of oligomeric Aβ assemblies that represent nuclei for fibrillization. Phosphorylated Aβ was detected in the brains of transgenic mice and human AD brains and showed increased toxicity in Drosophila models as compared with non-phosphorylated Aβ. Phosphorylation of Aβ could represent an important molecular mechanism in the pathogenesis of the most common sporadic form of AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527912      PMCID: PMC3117653          DOI: 10.1038/emboj.2011.138

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster.

Authors:  Alyce Finelli; Anju Kelkar; Ho-Juhn Song; Haidi Yang; Mary Konsolaki
Journal:  Mol Cell Neurosci       Date:  2004-07       Impact factor: 4.314

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

4.  Induced release of cell surface protein kinase yields CK1- and CK2-like enzymes in tandem.

Authors:  J Walter; M Schnölzer; W Pyerin; V Kinzel; D Kübler
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

5.  Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.

Authors:  A E Roher; M O Chaney; Y M Kuo; S D Webster; W B Stine; L J Haverkamp; A S Woods; R J Cotter; J M Tuohy; G A Krafft; B S Bonnell; M R Emmerling
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

6.  Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode.

Authors:  D Kübler; W Pyerin; O Bill; A Hotz; J Sonka; V Kinzel
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

7.  Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model.

Authors:  Tara L Spires-Jones; Melanie Meyer-Luehmann; Jennifer D Osetek; Phillip B Jones; Edward A Stern; Brian J Bacskai; Bradley T Hyman
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 8.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.

Authors:  Mark S Forman; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Med       Date:  2004-10       Impact factor: 53.440

9.  A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice.

Authors:  Melanie Meyer-Luehmann; Matthew Mielke; Tara L Spires-Jones; Will Stoothoff; Phill Jones; Brian J Bacskai; Bradley T Hyman
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

Review 10.  Protein misfolding and neurodegeneration.

Authors:  Claudio Soto; Lisbell D Estrada
Journal:  Arch Neurol       Date:  2008-02
View more
  75 in total

Review 1.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 2.  Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease.

Authors:  Tae-In Kam; Youngdae Gwon; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2014-08-24       Impact factor: 9.261

Review 3.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

4.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

5.  The aqueous phase of Alzheimer's disease brain contains assemblies built from ∼4 and ∼7 kDa Aβ species.

Authors:  Jessica M Mc Donald; Tiernan T O'Malley; Wen Liu; Alexandra J Mably; Gunnar Brinkmalm; Erik Portelius; William M Wittbold; Matthew P Frosch; Dominic M Walsh
Journal:  Alzheimers Dement       Date:  2015-04-04       Impact factor: 21.566

6.  Phosphorylation mapping of Laminin β1-chain: Kinases in association with active sites.

Authors:  Kleio-Maria Verrou; Panagiota Angeliki Galliou; Maria Papaioannou; Georgios Koliakos
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

7.  Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes.

Authors:  Sathish Kumar; Sandesh Singh; Désirée Hinze; Michaele Josten; Hans-Georg Sahl; Martin Siepmann; Jochen Walter
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

8.  Age-induced reduction of autophagy-related gene expression is associated with onset of Alzheimer's disease.

Authors:  Yasuhiro Omata; Young-Mi Lim; Yukihiro Akao; Leo Tsuda
Journal:  Am J Neurodegener Dis       Date:  2014-12-05

Review 9.  APP/Aβ structural diversity and Alzheimer's disease pathogenesis.

Authors:  Alex E Roher; Tyler A Kokjohn; Steven G Clarke; Michael R Sierks; Chera L Maarouf; Geidy E Serrano; Marwan S Sabbagh; Thomas G Beach
Journal:  Neurochem Int       Date:  2017-08-12       Impact factor: 3.921

10.  Peripherally applied synthetic peptide isoAsp7-Aβ(1-42) triggers cerebral β-amyloidosis.

Authors:  S A Kozin; I B Cheglakov; A A Ovsepyan; G B Telegin; P O Tsvetkov; A V Lisitsa; A A Makarov
Journal:  Neurotox Res       Date:  2013-05-14       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.